Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of DP-R207 vs Components in Healthy Male Volunteers
NCT02730689Phase 1Completed
- Sponsor
- Alvogen
- Start
- Dec 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of ezetimibe + rosuvastatin in hypercholesterolemia (2 arms), sponsored by Alvogen. Primary endpoints: Area under the plasma concentration versus time curve and Peak Plasma Concentration. Started Dec 2014; status: completed.
02
Drugs
ezetimibe + rosuvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02730689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02730689.